人类骨髓可能为EOMES+Tr1-Like细胞提供一个依赖IL-15的生存
Nadia Pulvirenti1, Chiara Vasco1, Camilla Righetti1
1Fondazione Istituto Nazionale di Genetica Molecolare Romeo ed Enrica Invernizzi, Milan, Italy.
European journal of immunology
|May 16, 2025
概括
骨髓为EOMES+类型-1调节 (Tr1) 类细胞提供了一个利基,与记忆T细胞不同. 这些类似Tr1的细胞依赖IL-15生存,与依赖IL-7的记忆T细胞不同.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 血液学 血液学 血液学
背景情况:
- 记忆T细胞和调节性T细胞 (Tr1) 对免疫平衡至关重要.
- 恒常性细胞因子介质素-7 (IL-7) 和介质素-15 (IL-15) 对于T细胞维护至关重要.
- 对于EOMES+ Tr1样细胞的长期命运和维持机制尚不清楚.
研究的目的:
- 调查EOMES+Tr1样细胞的长期维持和骨髓居住情况.
- 为了比较EOMES+Tr1样细胞与CD4+记忆T细胞的生存机制和细胞因子依赖.
- 探索骨髓作为特定T细胞种群的利基的作用.
主要方法:
- 在骨髓和周围血液中对T细胞群体 (CD4+,CD8+,EOMES+,GzmK+,GzmB+,CD69+,Ki67+,IL-7Rα,IL-2/15Rβ) 的流细胞计分析.
- 在体外培养实验以评估细胞存活率和细胞因子依赖性 (IL-7,IL-15).
- 基因表达分析 (强迫的EOMES表达).
主要成果:
- 在骨髓中发现表达GzmK的EOMES+Tr1样细胞处于静止状态并富含,与CD4+GzmB+效应T细胞不同.
- 骨髓中的CD4+记忆T细胞表达高IL-7Rα,而EOMES+Tr1样细胞是IL-7Rαlo,但表达IL-2/15Rβ.
- IL-15,但不是IL-7,从疏忽引起的死亡中拯救了EOMES+Tr1类细胞,表明了不同的生存途径.
结论:
- 骨髓是EOMES+Tr1类细胞的专门生存.
- IL-7和IL-15受体的明显表达模式表明,EOMES+Tr1-like细胞和CD4+记忆T细胞之间的竞争是为了获得同居静止的.
- 这些发现突出了骨髓中不同T细胞子集的差异性调节和维护策略.
更多相关视频
11:06Combining Intravital Fluorescent Microscopy IVFM with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches
Published on: March 21, 2017
7.9K
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
1.1K
相关概念视频
Stem Cell Niche
5.0K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.0K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Hematopoiesis
4.9K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
4.9K
